EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial

Ahmad Nofal, Hagar Nofal, Esam Alwirshiffani, Mohamed I ElGhareeb

Journal of the American Academy of Dermatology · 2023

DOI: 10.1016/j.jaad.2023.06.042 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2023. Verfasst von Ahmad Nofal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Warts, Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesWartsPapillomavirus InfectionsUterine Cervical NeoplasmsHumansFemaleHuman Papillomavirus VirusesHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Stichwörter der Autor:innen

CervarixGardasilbivalent HPV vaccinequadrivalent HPV vaccineverrucawart

Substanzen

Papillomavirus VaccinesHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; Biotechnology Program, School of Sciences and Engineering, the American University in Cairo, Cairo, Egypt. E…
  • Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; Faculty of Medicine, University of Tripoli, Tripoli, Libya.

Zitieren

APA

Nofal, A., Nofal, H., Alwirshiffani, E., & ElGhareeb, M. I. (2023). Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.06.042

Vancouver

Nofal A, Nofal H, Alwirshiffani E, ElGhareeb MI. Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial. Journal of the American Academy of Dermatology. 2023. doi:10.1016/j.jaad.2023.06.042

BibTeX
@article{Nofal2023,
  author = {Nofal, Ahmad and Nofal, Hagar and Alwirshiffani, Esam and ElGhareeb, Mohamed I},
  title = {Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial},
  journal = {Journal of the American Academy of Dermatology},
  year = {2023},
  doi = {10.1016/j.jaad.2023.06.042}
}
Kostenlos starten →